IH:NYSEiHuman Inc. Analysis

iHuman Inc. (IH) is trading at $1.76, just above its 20‑day SMA ($1.74) but still below the 50‑day ($1.81) and 200‑day ($2.41) averages, indicating short‑term momentum but a longer‑term bearish backdrop. The stock’s valuation appears deeply discounted, with a trailing P/E of 6.8x, a price‑to‑book of 0.62x and a price‑to‑sales of 0.11x, while the balance sheet is bolstered by $1.15 bn in cash against minimal debt. However, revenue has contracted 18% year‑over‑year and EPS is expected to fall from $0.26 to $0.19, reflecting operational pressure.
Technical indicators are mixed: RSI hovers near 50, the MACD histogram is marginally positive, yet the overall trend is flagged as bearish and 30‑day volatility is high at ~65%. The company faces medium‑to‑high regulatory risk in China’s education sector, low liquidity (average daily volume ≈12k versus today’s 712 shares), and modest beta (0.72), suggesting limited market correlation but heightened price swings. Given the cheap valuation and strong cash position, the stock may present a value‑oriented opportunity if the business can stabilize revenue and navigate regulatory headwinds.